Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

HealthCare Global Enterprises Ltd - 539787 - Announcement Under Regulation 30 And 31A Of SEBI (LODR) Regulations 2015

 We wish to inform you that the Company has received the approval from National Stock Exchange of India Limited and BSE Limited, on April 05, 2021 for reclassification of the following members of Promoter and Promoter Group to Public Shareholders, in terms of Regulation 31A of SEBI LODR Regulations. 1) Dr. B.S. Ramesh; 2) Dr. Ganesh Nayak; 3) Ms. Venkatesh Sudha; 4) Mr. Pradeep Nayak; 5) Mr. Adarsh Ramesh; 6) Dr. M. Gopichand 7) Dr. K.S. Gopinath; 8) Mr. Prakash Nayak; and 9) Mr. Srinivas K. Gopinath.
06-04-2021

HealthCare Global survived Covid-19 with robust hub & spoke model

 HealthCare Global Enterprises Limited (HCG), a cancer hospital chain, witnessed a dip of nearly 50 per cent of patient inflow in its hospitals due to
01-04-2021
Bigul

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Resignation of Director

 This is to inform you that Dr. Amit Varma (DIN: 02241746), Non-Executive, Non-Independent Director, has resigned from the Board of the Company ('Board') with effect from April 01, 2021. He has informed that his resignation is due to professional commitments. The Board has accepted and taken on record the resignation of Dr. Amit Varma as a Director; and accordingly, he ceases to be a Director on the Board with effect from April 01, 2021.
01-04-2021
Bigul

HealthCare Global Enterprises Ltd - 539787 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aceso Company Pte Ltd
29-03-2021
Bigul

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Meeting with the investors/funds/analysts on the general business overview and financial highlights of the Company for the quarter and nine months ended 31 December 2020 as per the earnings presentation, sent to the Stock Exchanges vide our letter dated February 11, 202
26-03-2021
Bigul

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Meeting with the investors/funds/analysts on the general business overview and financial highlights of the Company for the quarter and nine months ended 31 December 2020 as per the earnings presentation, sent to the Stock Exchanges vide our letter dated February 11, 202
26-03-2021
Bigul

HealthCare Global Enterprises Ltd - 539787 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. B.S. Ajaikumar
19-03-2021
Bigul

HealthCare Global Enterprises Ltd - 539787 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. B.S. Ajaikumar
19-03-2021
Bigul

HealthCare Global Enterprises Ltd - 539787 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. B.S. Ajaikumar
19-03-2021
Bigul

HealthCare Global Enterprises Ltd - 539787 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr B S Ajaikumar
17-03-2021
Next Page
Close

Let's Open Free Demat Account